Events Details
Livzon Pharma plans industry fund, unit in alliance with Epirus Switzerland
Friday, September 25, 2015
Livzon Pharmaceutical Group Inc says unit Livzon Mabpharm signs collaboration agreement with Switzerland's Epirus Switzerland.
* Says plans to set up industry fund worth 500 million yuan ($78.35 million) with partner.
reuters.com
